Research Study: More evidence for Ivermectin superiority and efficacy.
https://childrenshealthdefense.org/defender/ivermectin-beats-meds-treating-omicron/
This is a study that is in preprint (not yet peer-reviewed) on Cornell University's website. Researchers used a computational analysis to evaluate the performance of 10 medications against the Omicron variant, finding Ivermectin outperformed all of them, including nirmatrelvir (Paxlovid), a new drug from Pfizer that has cost taxpaers US$529 per course of treatment.
Comments
Post a Comment